NDRAENDRA Life Sciences Inc.

Nasdaq endrainc.com


$ 0.10 $ 0.00 (1.12 %)    

Wednesday, 26-Jun-2024 14:38:22 EDT
QQQ $ 478.82 $ -0.78 (-0.16 %)
DIA $ 391.30 $ 1.19 (0.31 %)
SPY $ 544.32 $ 0.72 (0.13 %)
TLT $ 93.19 $ -0.37 (-0.4 %)
GLD $ 212.48 $ -1.71 (-0.8 %)
$ 0.1031
$ 0.10
$ 0.10 x 100
$ 0.15 x 3,900
$ 0.09 - $ 0.10
$ 0.07 - $ 2.79
13,453,018
na
1.14M
$ 1.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-16-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-14-2020 03-31-2020 10-Q
18 03-26-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 03-11-2019 12-31-2018 10-K
23 11-05-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-20-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-07-2017 06-30-2017 10-Q
29 06-21-2017 03-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-endra-life-sciences-stock-is-trading-higher-monday

ENDRA Lifesciences filed a 13G form showing that S.H.N. Financial Investments had a 9.99% passive stake in the company.

 endra-life-sciences-13g-filing-shows-shn-financial-investments-ltd-reported-a-999-stake-in-the-co-as-of-june-4-2024

- SEC Filing

 endra-life-sciences-granted-european-patent-ep4021284-titled-method-and-system-for-determining-at-least-one-parameter-of-interest-of-a-material-for-use-in-thermoacoustic-ultrasonic-imaging

https://data.epo.org/publication-server/publications/pdf?path=2024/24/DOC/EPNWB1/EP20856500NWB1/EP20856500NWB1.pdf

 ascendiant-capital-maintains-buy-on-endra-life-sciences-lowers-price-target-to-8

Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target fro...